These battered biotech stocks are now buying opportunities as Elizabeth Warren climbs in the polls
October 11, 2019 at 05:18 AM EDT
Sen. Elizabeth Warren’s health-care reform crusade is rattling biotech investors — but that’s not the industry’s only problem, writes Michael Brush.
